Detalhe da pesquisa
1.
Treatment of HR+/HER2- breast cancer in urban mainland China: results from the CancerMPact Survey 2019.
Breast Cancer Res Treat
; 195(3): 441-451, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35986800